Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid
Xiaojie Xu(Dalian Medical University), Mei Li(Jiangsu University), Weibo Xia(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Asan(BGI Group (China)), Lijie Song(BGI Group (China)), Yi Liu(Mayo Clinic in Florida), Jiawei Wang(Tsinghua University), Jianyi Wang(BGI Group (China)), Ou Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Lv(Liaoning Normal University), Doudou Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoping Xing(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 20
Related Papers
Whole-genome sequencing of quartet families with autism spectrum disorder
|Nature Medicine|2015|540
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115